Introduction
============

In the 1970s, circRNAs were first reported in plant viroids [@B1]. Through observation using an electron microscope, circRNAs were proven to exist in the eukaryotic cytoplasm [@B2]. Moreover, ciRNA and EIciRNA were subsequently detected in the nucleus of eukaryotes [@B3]-[@B5]. CircRNAs were found as a class of noncoding RNA without 5\' caps and 3\' ploy (A) tails [@B6]. Different from linear noncoding RNAs, such as long noncoding RNA (lncRNA) and miRNAs, circRNAs have a covalently closed ring shape and are insensitive to exonuclease R, which leads to the stabilization of the structure [@B7].

With the development of bioinformatics, most studies showed a variety of circRNA played an important role in various diseases. To explore the circRNA role in diabetes and depression, Jiang et al. found 183 upregulated hsa-circRNAs and 64 downregulated hsa-circRNAs in the treatment group. KEGG results showed that potential circRNAs might be involved in the thyroid hormone, Wnt, ErbB, and mitogen-activated protein kinase signaling pathways [@B8]. Moreover, dysregulated circRNAs were implicated in osteogenesis, diabetes mellitus and brain dysfunction, especially cancer [@B9]-[@B11]. Recently, Huang et al. recognized several differentially expressed circRNAs using a circRNA microarray. Furthermore, circRNA_100338, one of the upregulated circRNAs, promoted invasive potential of hepatitis B-related hepatocellular carcinoma [@B12]. CircFAT1 (e2), as a novel circular RNA, has been reported to inhibit gastric cancer progression [@B13]. One intronic circRNA derived from CTNNB1 (circ-CTNNB1) was upregulated in several cancer including gastric cancer, prostate cancer and colon cancer. Function identification showed that circ-CTNNB1 promoted β-catenin activation, growth, invasion, and metastasis in these cancer cells [@B14]. These studies suggested that circRNAs might be key regulators in cancer progression.

Due to the change of human eating habits, digestive cancers are very common in the world, such as colorectal cancer, gastric cancer and esophageal squamous cell carcinoma [@B15]-[@B17]. Therefore, it is essential for increasing the survival rate of digestive cancer patients via early diagnosis and therapy [@B18]. In this study, we summarized a series of studies on circRNA biogenesis and its regulation. We also discussed circRNA functions, mechanisms and potential clinical significance in digestive cancers.

Biogenesis and regulations of circRNA
=====================================

Increasing circRNAs were identified by microarray or high-throughput sequencing, but the biogenesis of circRNA is still elusive. Recently, some researchers have found that intron pairing, exon skipping, and RNA binding protein (RBP) pairing were the main reasons that drove the circularization of RNA (Figure [1](#F1){ref-type="fig"}) [@B7], [@B19]-[@B22]. In 2012, Jeck et al. identified a number of "backsplices" by high-throughput sequencing. The features of the circularized exons were driven by intron-pairing, which contained complementary ALU repeats using bioinformatic analysis [@B23]. Additional evidence strengthened the present theory that reverse complementary matches (RCMs) in circRNA flanking introns are the key step of circRNA biogenesis, which was diminished by enzyme adenosine deaminase 1 (ADAR1) [@B22]. Exon-skipping events are another mainstream hypothesis for circularization. A study reported that exon-skipping promoted the shaping of a spliced lariat containing the circularized exon [@B20]. Moreover, RNA binding protein showed a potential induction in circRNA formation. Quaking is an RNA binding protein that affects the circRNA abundance related to the intronic Quaking binding motifs [@B21]. As a result, the flanking complementary sequences could promote back-splicing, further shaping circRNAs. Recently, Xiang et al. reported that the immune factors, NF90/NF110, enhanced the formation of back-splicing in the nucleus, which suggested that NF90/NF110 was involved in circRNA biogenesis [@B24]. Recently, the processing of circRNA was reported in eukaryotes. Ling et al. showed that circRNAs in eukaryotes were from pre-mRNA reverse splicing, and its productions were correlated with the extension rate of Pol II [@B25].

Based on the adequate biogenesis studies of circRNA, increasing studies have focused on its regulation (Figure [1](#F1){ref-type="fig"}). Currently, circRNAs play an important role via sponging miRNAs, interacting with proteins or being translated into functional small peptide [@B26]-[@B28].

miRNA sponge
------------

It is well known that lncRNAs could be endogenous sponges that bind to their target miRNAs because of the presence of the microRNA response element (MRE) in lncRNA sequences [@B29]. Subsequently, Thomas B et al. proved that circRNAs are implicated in the ceRNA mechanism as an miRNA sponge. A previous study showed a high level of circRNA expression in mouse and human brains [@B28]. Further study found that a circRNA has more than 70 certain miRNA seed match segments and could be a sponge of miR-7 [@B27]. A world of circRNA functions was opened and increasing evidences had shown a wide range of regulation mechanisms by the circRNA-miRNA axis.

An exonic circRNA, ciRS-7, was found to have 63 conserved miRNA target sites of miR-7 and was bound by AGO complexes [@B30]. Monika et al. verified that ciRS-7 could be bound by AGO miRNA complexes with miR-7 and miR-671. Deficiency of the ciRS-7 gene led to the dysfunction of draining, including sensorimotor gating damage and abnormal synaptic transmission. A miR-7 target, the Fos gene, is upregulated in the ciRS-7 deficient group and showed a potential relationship with the behavioral phenotype in mouse [@B11]. Knockdown ciRS-7 or miR-7 showed that ciRS-7 was proposed as an anti-miRNA circRNA, which is crucial to normal brain function. Similarly, Kun et al. identified a heart-related circRNA, HRCR, which could be bound by miR-223. ARC was verified as a downstream target of miR-223 by RNAhybrid prediction and target protector technology. Overexpressed miR-223 promoted hypertrophy in the mouse heart and cardiomyocytes. Interestingly, enhanced HRCR expression showed a contrasting effect *in vivo* and*in vitro*, which implied that HRCR could restrain the development of heart disease [@B31]. In cancer, accumulated studies verified that circRNAs could function similar to ceRNA, regulating tumor progression. Upregulated circUBAP2 in human osteosarcoma indicated a poor patient prognosis. It accelerated tumor growth and suppressed apoptosis by sponging miR-143 and releasing the miR-143 direct target, anti-apoptotic Bcl-2 [@B32], [@B33]. Resembling circUBAP2, circ_0001982 presented a tumor suppressor effect by sponging miR-143 in breast cancer cells [@B34]. CircRNA_100290 was another identified circRNA in oral cancer by microarray technology. Through competitively binding miR-29b, silencing of circRNA_100290 markedly inhibited the expression level of CDK6. As a target of miR-29b, CDK6 combined with cyclin promoted the cell cycle from G1 phase to S phase [@B35]-[@B37]. There are many studies of circRNA-miRNA regulation. These studies suggested that circRNAs sponging miRNAs showed complex regulation networks in cancer and disease, and more ceRNAs of circRNAs will be found in the future.

Interaction with protein
------------------------

Previous studies have revealed that circRNAs could influence pre-mRNA and regulate parental gene expression. Ashwal-Fluss et al. found a conserved muscle-blind binding site in the flanking sequences of circRNA, circMbI. Interestingly, intensive research showed that MBL could specifically bind with circMbI and showed a forceful influence in the biosynthesis of circMbI. This study illustrated a function of circRNA in transcription via competing with pre-mRNA splicing [@B38]. The others of circRNA in regulating transcription display an effect on the parental gene. Cir-ITCH is one of the circRNAs that modulates the parental gene through sponging miRNA. Based on common miRNA binding sites in circITCH and the ITCH sequence, circITCH competitively bound with miR-7, miR-17, and miR-214, indirectly increasing ITCH expression [@B39]. As we showed, the sequence of EIciRNAs contained the exon and its flanking intron. A classical study reported that EIciRNAs, such as circEIF3J and circPIAP2 in the nucleus, promoted parental gene transcription via shaping EIciRNAs-U1 snRNP complexes and interacting with Pol II, which suggested that EIciRNAs could bind with the protein and had an effect on the regulation of transcription of the parental gene [@B5]. In addition, exonic circular RNAs, as regulators, play identical roles in combining with proteins. Upregulated circ-Foxo3 in non-cancer cells was correlated with the cell cycle. An interesting result showed that circ-Foxo3 bound to CDK2 and p21, forming an RNA-protein complex to arrest the cell cycle [@B40].

Translation into small peptides
-------------------------------

Recent studies indicated that circRNA could be translated into the protein. Additionally, a non-circle structure, internal ribosome entry site (IRES), is the key aspect of circRNA translation into a protein. Nagarjuna et al. found several translating circRNAs in the fly head. These circRNAs not only retained conservative termination codons in evolution but could also be bound to the ribosome utilizing the start codon of its host mRNA. This translation course was possibly regulated by starvation and FOXO [@B41]. Similar to the fly head, anendogenous circular RNA, FBXW7, contained an IRES, which could be encoded by a 21 kDa protein in the human brain. A functional study displayed the suppressor role of the FBXW7 protein in malignant phenotypes of human glioblastoma [@B42]. These studies strongly proved that endogenous circRNAs had a translation capacity, which exploited a new field of circRNA function.

Dysregulated circRNAs in digestive cancers
==========================================

CircRNAs are a new member of the non-coding RNA family. Genome-wide statistical analysis promoted the discovery of circRNAs in multiple cancer tissues [@B12], [@B43]. Through microarray technology, 125 circRNAs were upregulated and 76 circRNAs were identified in paired colorectal cancer tissues and normal tissues [@B44]. Similarly, compared with the normal tissues, 522 downregulated and 191upregulated circRNAs were identified in gastric cancer. Further online functional analysis showed that these dysregulated circRNAs were involved in carcinogenesis [@B45]. Radiotherapy is a primary method of oncotherapy. Acquired radioresistance led to a decline in patient survival. Recently, a study showed that dysregulated circRNAs were implicated in radioresistant esophageal cancer cells. Most of their target genes were enriched in the Wnt signaling pathway, which implied that these circRNAs exert their regulation in resistance to esophageal cancer through the Wnt signaling pathway [@B46]. As we showed, dysregulated circRNAs exist in digestive cancers and may play important roles in digestive cancers (Table [1](#T1){ref-type="table"}).

Role of circular RNA in digestive cancers
=========================================

Recently, most studies showed that circRNAs are important regulators involved in cancer progression. Moreover, these circRNAs play double roles which could excert different functions through different regulations in digestive cancers (Figure [2](#F2){ref-type="fig"}).

Onco-circRNA
------------

The expression of circular BANP was reported to be upregulated in colorectal cancer tissues compared to its adjacent normal tissues. Through cellular localization analysis, circ-BANP was shown to primarily exist in the cytoplasm. Silencing circ-BANP expression inhibited colorectal cell proliferation, which implied that circ-BANP was an oncogene in colorectal cancer [@B58]. High expression levels of circ_0000069 in colorectal cancer performed a similar function in promoting cell proliferation, migration, and invasion [@B55]. In esophageal squamous cell carcinoma, increased circ_0067934 was identified compared with adjacent normal tissues. The results of knocking down circ_0067934 showed inhibiting effect on cancer cell proliferation and migration [@B51]. Increasing miRNAs were implicated in the regulation of circRNA. Based on RNA-Seq and functional analysis, circPVT1 was identified as an oncogene in gastric cancer. Moreover, miR-125 families could be bound by circPVT1 [@B59]. Another positive circRNA, circ_001569 assisted the gene expression of miR-145 targets, E2F5, BAG4 and FMNL2 [@B52]. High expression level of circHIPK3 was identified in colorectal cancer and promoted the cancer growth and metastasis by sponging miR-7 [@B60]. In addition, circRNAs were involved in signaling pathways regulated by miRNA. Recently, the PTEN/PI3K/Akt signaling pathway was frequently discussed in cancer. Inhibiting PTEN, which attenuates the activity of Akt or increasesPI3K and Akt, could block tumor cell apoptosis [@B61], [@B62]. Overexpression of ciRS-7 in gastric cancer could relieve the braking effect of miRNAs on regulating the PTEN/PI3K/Akt signaling pathway [@B63]. These evidences suggested that circRNAs could be as positive regulators to promote digestive cancer progression.

Anti-oncogene circRNA
---------------------

Adversely, few studies illustrated that certain circRNAs, as anti-oncogene, were involved in digestive cancers. There was low expression of circ-104916 in gastric cancer tissues. Overexpressed circ-104916 hindered cell proliferation, migration and invasion via regulating key factors of the EMT process [@B64]. By sponging onco-miRNA, upregulated circRNA_100269 and circ-LARP4 inhibited gastric cancer cell proliferation and invasion *in vitro* [@B65], [@B66]. As we previously discussed, circ-ITCH implemented its function by modulating its parental genes via sponging miRNA. In colorectal cancer and esophageal squamous cell carcinoma, circ-ITCH played a suppressive role and bound to the miRNA, impeding the Wnt/β-Catenin pathway [@B39], [@B67]. CircITGA7 was found to suppress cell growth and metastasis via inhibiting the Ras signalling pathway and promoting the transcription of its host gene ITGA7 in colorectal cancer [@B68]. Those results implied that circRNA could be as anti-oncogene to be involved in digestive cancer progression.

Clinical application in digestive cancers
=========================================

In recent years, digestive cancer has high morbidity and high mortality. Although most tumor markers have been found and applied in clinical detection, their sensitivity and veracity are still barely satisfactory. CircRNAs are novel noncoding RNAs with a number of observable and stable ectopic-circRNAs present in digestive cancer [@B30]. Yan et al. identified 48 dysregulated circRNAs and illustrated a tight link with four circRNAs and early recurrence in gastric cancer patients with stage III cancer after radical surgery [@B69]. Downregulated circ_0000190 in gastric cancer indicated a correlation with tumor diameter, lymphatic metastasis, distal metastasis, TNM stage, and CA19-9 levels [@B54]. In colorectal cancer, circ_001988 was reported as a new biomarker due to its significant clinical behavior [@B70]. These studies illustrate that circRNAs are promising biomarkers in the diagnosis and treatment digestive cancers based on their functions.

Exosomes is extracellular vesicles which secrected by many cell type. Then they release into the variety of body fluids, such as serum, saliva, urine, amniotic fluid and cerebrospinal fluid for intercellular communication [@B71]-[@B73]. Exosomes derived from cancer cells were found to have great clinical applications in cancer because they could be drivers containing biomacromolecules. Recently, a study reported that enriched and stable circRNAs were identified in the serum exosomes derived from colorectal cancer patient. The process of how circRNAs move from the cancer cell to the body fluid is assisted by the exosome [@B74]. It was a breakthrough of circRNA potentially applying clinical transformation.

Conclusion
==========

From trash to treasure, our understanding of circRNAs is gradually increasing in recent years. To date, exon skipping, intron pairing and RBP pairing were the main reasons of RNA circularization [@B7], [@B19]-[@B22]. In addition, Ling et al. thought that there verse splicing of pre-mRNAs was the main source for circRNAs in eukaryotes [@B25]. Through sponging the miRNA, interacting with protein, and translating into small peptides, circRNAs showed diverse regulatory mechanisms. Digestive cancers are the most common cancers in the world. Using RNA sequencing technology provided us more circRNAs that were identified from esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer. These circRNAs played double roles in the development of digestive cancer, implying potential applications in clinical diagnosis and therapy. Where do circRNAs come from? How are they regulated? What is their role in digestive cancers? These three questions are indispensable to be solved by further studies. Therefore, there are still other unknown circRNA functions and regulatory mechanisms that need to be investigated in the future.
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Dysregulated circRNA in digestive cancers.

  circRNA            Location                   Gene symbol   Cancer                               Dysregulation   Ref
  ------------------ -------------------------- ------------- ------------------------------------ --------------- --------
  hsa_circ_0074362   chr5:142264862-142311690   ARHGAP26      Gastric cancer                       Downregulated   [@B47]
  hsa_circ_0000520   chr14:20811436-20811559    RPPH1         Gastric cancer                       Downregulated   [@B48]
  hsa_circ_0047905   chr18:61156579-61172318    SERPINB5      Gastric cancer                       Upregulated     [@B49]
  hsa_circ_0138960   chr9:74817486-74828907     GDA                                                                
  hsa_circ_0000745   chr17:20107645-20109225    SPECC1        Gastric cancer                       Downregulated   [@B50]
  hsa_circ_0067934   chr3:170013698-170015181   PRKCI         Esophageal squamous cell carcinoma   Upregulated     [@B51]
  hsa_circ_0000677   chr16:16101672-16162159    ABCC1         Colorectal cancer                    Upregulated     [@B52]
  hsa_circ_0003159   chr7:81689743-81746489     CACNA2D1      Gastric cancer                       Downregulated   [@B53]
  hsa_circ_0000190   chr1:224553580-224559125   CNIH4         Gastric cancer                       Downregulated   [@B54]
  hsa_circ_0000069   chr1:47745912-47748131     STIL          Colorectal cancer                    Upregulated     [@B55]
  hsa_circ_0001724   chr7:92462409-92463134     CDK6          Colorectal cancer                    Upregulated     [@B56]
  hsa_circ_0026344   chr12:52314542-52317145    ACVRL1        Colorectal cancer                    Downregulated   [@B57]
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